5-(2-bromovinyl)uracil,
5-bromovinyluracil,
(E)-5-(2-Bromovinyl)uracil,
69304-49-0,
Bromovinyluracil,
BV uracil,
5-(2-Bromovinyl)uracil,
(E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione,
CCRIS 5284,
BRN 0744244,
(E)-5-(2-Bromoethenyl)-2,4(1H,3H)-pyrimidinedione,
5-[(E)-2-bromoethenyl]-1H-pyrimidine-2,4-dione,
W-203539,
5-(trans-2-bromovinyl)-uracil,
2,4(1H,3H)-Pyrimidinedione, 5-(2-bromoethenyl)-, (E)-,
5-bromovinyluracil,
AC1LELS0,
E-5-(2-bromovinyl)uracil,
SCHEMBL65892,
5-24-07-00368 (Beilstein Handbook Reference),
CHEMBL68200,
5-((E)-2-Bromovinyl)uracil,
ZINC57050,
BLXGZIDBSXVMLU-OWOJBTEDSA-N,
BCP24262,
AKOS015892588,
(E)-5-(2-Bromovinyl)uracil, 97%,
FCH1320058,
FCH3703559,
AJ-09553,
AX8046644,
LS-135118,
16437-EP2281563A1,
16437-EP2316459A1,
5-[(E)-2-bromovinyl]-1H-pyrimidine-2,4-dione,
Brivudine Impurity ((E)-5-(2-Bromovinyl)uracil ),
I03-1659,
5-[(1E)-2-Bromoethenyl]-2,4(1H,3H)-pyrimidinedione,
2,4(1H,3H)-Pyrimidinedione, 5-[(1E)-2-bromoethenyl]-,
C6H5BrN2O2,
-5- URACIL,
C6-H5-Br-N2-O2,
CID688297,